The impact of COVID-19 on colorectal cancer in regional Northern Queensland and changes to treatment related to distance to care

Not Applicable

Completed

• Conditions: colorectal cancer; COVID-19; Surgery - Other surgery; Infection - Other infectious diseases; Cancer - Bowel - Back passage (rectum) or large bowel (colon); Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12624000396527
• Lead Sponsor: Richard Maguire

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-01-31
• Study Start: 2024-04-03
• Last Update Posted: 8 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

all patients that were diagnosed or treated for colorectal cancer during the time periods being analysed and definitively managed at the Townsville University Hospital

Exclusion Criteria

patients treated for benign pathology and for non colonic/rectal adenocarcinoma i.e. anal scc

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
primary aim to review number of emergency presentations with more advanced disease in terms of colorectal cancer during the COVID 19 pandemic compared to the Pre-COVID time period.[The number of emergency presentations will be compared between the 2 time periods prevoid-19 and during covid-19<br>March 2019-July 2019) vs <br> COVID March 2020-July 2022.<br>Pre covid<br>March 2019-July 2019) March 2020-July 2022]